Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2

Details for Australian Patent Application No. 2004230938 (hide)

Owner Amgen Inc.

Inventors Oliner, Jonathan Daniel; Min, Hosung

Agent Shelston IP

Pub. Number AU-A-2004230938

PCT Pub. Number WO2004/092215

Priority 10/410,998 09.04.03 US

Filing date 8 April 2004

Wipo publication date 28 October 2004

International Classifications

C07K 016/22 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C07K 019/00 Hybrid peptides

A61K 038/00 Medicinal preparations containing peptides

C07K 014/515 Peptides having more than 20 amino acids

C07K 007/00 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/092215 Priority application(s): WO2004/092215

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230946-Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

2004230936-Amphibious vehicle